Mucin 2 and occludin play a crucial role in preserving the intestinal mucosal integrity. However, the role for leucine mediating intestinal mucin 2 and occludin expression has little been investigated. The current stu...Mucin 2 and occludin play a crucial role in preserving the intestinal mucosal integrity. However, the role for leucine mediating intestinal mucin 2 and occludin expression has little been investigated. The current study was conducted to test the hypothesis that leucine treatment could increase mucin 2 and occludin levels in LS174 T cells. The LS174 T cells were incubated in the Dulbecco's Modified Eagle Medium(DMEM)supplementing 0, 0.5 and 5 mmol/L L-leucine for the various durations. Two hours after the leucine treatment, the inhibitor of mammalian target of rapamycin(mTOR) and protein kinase B(Akt) phosphorylation in LS174 T cells were significantly increased(P < 0.05), and the mucin 2 and occludin levels were also significantly enhanced(P < 0.05). However, the pretreatment of 10 nmol/L rapamycin, which was an mTOR inhibitor, or 1 μmol/L wortmanin, which was an inhibitor of phosphatidylinositol 3-kinase(PI3 K), completely inhibited leucine-induced mTOR or Akt phosphorylation(P < 0.05), and significantly reduced leucine-stimulated mucin 2 and occludin levels(P < 0.05). These results suggest that leucine treatment promotes the mucin 2 and occludin levels in LS174 T cells partially through the PI3 K-Akt-mTOR signaling pathway.展开更多
基金financially supported by the grant from the National Natural Science Foundation of China (31201812)the earmarked fund for the China Agriculture Research System(CARS-36)the grant from the Science and Technology Support Program of Sichuan Province(13ZC2237)
文摘Mucin 2 and occludin play a crucial role in preserving the intestinal mucosal integrity. However, the role for leucine mediating intestinal mucin 2 and occludin expression has little been investigated. The current study was conducted to test the hypothesis that leucine treatment could increase mucin 2 and occludin levels in LS174 T cells. The LS174 T cells were incubated in the Dulbecco's Modified Eagle Medium(DMEM)supplementing 0, 0.5 and 5 mmol/L L-leucine for the various durations. Two hours after the leucine treatment, the inhibitor of mammalian target of rapamycin(mTOR) and protein kinase B(Akt) phosphorylation in LS174 T cells were significantly increased(P < 0.05), and the mucin 2 and occludin levels were also significantly enhanced(P < 0.05). However, the pretreatment of 10 nmol/L rapamycin, which was an mTOR inhibitor, or 1 μmol/L wortmanin, which was an inhibitor of phosphatidylinositol 3-kinase(PI3 K), completely inhibited leucine-induced mTOR or Akt phosphorylation(P < 0.05), and significantly reduced leucine-stimulated mucin 2 and occludin levels(P < 0.05). These results suggest that leucine treatment promotes the mucin 2 and occludin levels in LS174 T cells partially through the PI3 K-Akt-mTOR signaling pathway.
